A clinical trial has 120 participants. 70 respond to therapy X, 50 respond to therapy Y, and 25 respond to both. How many show no response to either therapy? - Deep Underground Poetry
A clinical trial has 120 participants. 70 respond to therapy X, 50 respond to therapy Y, and 25 respond to both. How many show no response to either therapy?
When new treatments enter clinical trials, understanding how different groups respond is key to assessing efficiency and accessibility. In one recent study involving 120 participants, detailed response rates revealed a nuanced picture of therapy effectiveness—70 responded to therapy X, 50 to therapy Y, with 25 showing responses to both. Yet, behind these numbers lies a deeper question: how many patients did not respond at all? This figure matters—not only for researchers evaluating outcomes but for patients and advocates seeking clarity on treatment viability. In a digital environment where health information spreads quickly, such data drives informed decisions and sparks meaningful conversation across communities.
A clinical trial has 120 participants. 70 respond to therapy X, 50 respond to therapy Y, and 25 respond to both. How many show no response to either therapy?
When new treatments enter clinical trials, understanding how different groups respond is key to assessing efficiency and accessibility. In one recent study involving 120 participants, detailed response rates revealed a nuanced picture of therapy effectiveness—70 responded to therapy X, 50 to therapy Y, with 25 showing responses to both. Yet, behind these numbers lies a deeper question: how many patients did not respond at all? This figure matters—not only for researchers evaluating outcomes but for patients and advocates seeking clarity on treatment viability. In a digital environment where health information spreads quickly, such data drives informed decisions and sparks meaningful conversation across communities.
Understanding the Numbers
Behind the statistics, 120 participants form the foundation of this analysis. Seventy responded positively to therapy X alone, fifty to therapy Y alone, and twenty-five achieved benefits from both. To find those untouched by either therapy, subtract overlapping responses from total responders. There are 70 + 50 = 120 total individual responses before adjusting for overlap. But because 25 participants responded to both, those individuals are counted twice if not corrected. Subtracting the 25 double-counted responses gives 120 – 25 = 95 who responded in some way. With 120 total participants, the remaining show no response—120 – 95 = 25 participants responded to neither therapy.
Why This Data Matters
In the U.S., interest in clinical trial outcomes grows as more individuals seek cutting-edge treatments and transparency. Understanding how large subgroups respond—or don’t—shapes conversations about treatment accessibility, equity, and real-world applicability. These numbers
